company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,51507000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,51507000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21487000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21487000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30020000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4586000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,14444000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5242000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2267000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26539000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3481000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,124000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,167000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-571000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-528000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2953000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1065000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1888000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1888000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1888000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24755000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25032000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23600000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q1,2010-06-01,2010-08-31,2011-10-11 16:00:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53372000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53372000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21836000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21836000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31536000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4173000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,13793000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5259000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2142000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,772000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26139000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5397000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,116000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,161000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-307000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-262000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5135000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1856000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3279000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3279000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3279000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24845000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25094000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q2,2010-09-01,2010-11-30,2012-01-05 16:31:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,54648000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,54648000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22927000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22927000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31721000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4346000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,14553000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5322000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2252000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26473000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5248000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,119000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,208000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-267000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-178000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5070000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1259000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3811000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3811000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3811000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24902000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.15
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25174000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25400000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q3,2010-12-01,2011-02-28,2012-04-09 16:00:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.15
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,56223000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,56223000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23797000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23797000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,32426000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4723000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,15333000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5550000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2573000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,6410000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34589000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2163000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,140000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,201000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-358000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-297000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2460000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1599000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-861000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-861000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-861000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24870005.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25132763.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24600000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2011.0,Q4,2011-03-01,2011-05-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,54431000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,54431000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22285000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22285000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,32146000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4312000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,16308000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5591000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2295000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,923000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29429000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2717000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,116000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,235000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-733000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-614000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2103000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,730000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1373000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1373000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1373000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25024000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.05
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25197000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27500000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q1,2011-06-01,2011-08-31,2012-11-09 10:38:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.05
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,58099000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,58099000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24868000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24868000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,33231000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4625000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,15847000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5125000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2300000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1408000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29305000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3926000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,111000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,260000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-506000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-357000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3569000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1240000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2329000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2329000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2329000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25190000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25340000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q2,2011-09-01,2011-11-30,2013-01-09 14:54:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,51567000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,51567000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22153000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22153000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29414000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4434000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,15802000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4574000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2320000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5041000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32171000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2757000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,102000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,305000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-326000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-123000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2880000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1112000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1768000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1768000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1768000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25129000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25129000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q3,2011-12-01,2012-02-29,2013-04-09 16:08:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,57690000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,57690000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,26523000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,26523000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31167000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4963000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,16548000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5221000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2491000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,8792000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38015000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6848000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,179000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,290000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1337000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1226000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8074000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1046000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7028000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7028000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7028000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25382293.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25382293.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25500000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2012.0,Q4,2012-03-01,2012-05-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,83406000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,83406000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,43947000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,43947000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,39459000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6899000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,18543000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7074000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3737000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2522000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38775000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,684000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1332000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,82000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-588000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1838000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1154000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-433000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-721000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-721000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-721000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34704000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34704000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q1,2012-06-01,2012-08-31,2013-10-10 16:31:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,87007000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,87007000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,42919000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,42919000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,44088000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6910000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,18671000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7014000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4107000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,197000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2067000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38966000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5122000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1383000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-628000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1990000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3132000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1163000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1969000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1969000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1969000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34827000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35311000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q2,2012-09-01,2012-11-30,2014-01-09 16:35:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,81571000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,81571000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,40370000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,40370000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41201000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6046000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,18520000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5793000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4314000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1313000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5157000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41143000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,58000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1271000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-608000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1879000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1821000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-829000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-992000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-992000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-992000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34834000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34834000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33100000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q3,2012-12-01,2013-02-28,2014-04-09 16:23:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,89932000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,89932000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,46166000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,46166000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43766000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6331000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,20387000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6438000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4459000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1673000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4054000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43342000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,424000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1285000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-883000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2168000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1744000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-277000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1467000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1467000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1467000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34817279.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34817279.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2013.0,Q4,2013-03-01,2013-05-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40400000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,83644000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,83644000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,41064000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,41064000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,42580000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6686000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,19963000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6709000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4109000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1709000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2002000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41178000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1402000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1246000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-719000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1965000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-563000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-190000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-373000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-373000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-373000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34950000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34950000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37300000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q1,2013-06-01,2013-08-31,2014-10-15 17:30:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,88571000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,88571000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,43686000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,43686000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,44885000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6411000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,21073000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7003000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4339000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1939000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2679000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43444000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1441000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,959000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-832000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1791000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-350000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-89000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-261000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-261000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-261000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35132000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35132000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26100000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q2,2013-09-01,2013-11-30,2015-01-09 17:10:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,88150000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,88150000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,43357000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,43357000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,44793000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6445000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,20700000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7045000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4248000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-3174000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3016000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38280000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6513000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,917000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1053000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1970000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4543000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,28000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4515000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4515000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4515000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35184000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35704000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34700000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2014.0,Q3,2013-12-01,2014-02-28,2015-04-09 16:51:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,87331000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,87331000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,41506000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,41506000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,45825000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7323000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,20067000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6718000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4015000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1796000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2664000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42583000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3242000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,799000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1025000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1824000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1418000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,948000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,470000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,470000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,470000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35367000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.01
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35885000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.01
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47000000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q1,2014-06-01,2014-08-31,2015-10-08 16:36:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.01
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,92149000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,92149000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,44493000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,44493000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,47656000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7973000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,20983000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6069000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4061000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1693000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2302000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43081000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4575000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,793000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-954000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1746000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2829000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1491000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1338000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1338000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1338000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35595000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36127000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33500000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q2,2014-09-01,2014-11-30,2016-01-08 16:28:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,86597000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,86597000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,48746000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,48746000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,37851000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6917000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,19355000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6855000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5106000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-9010000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,18779000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48002000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10151000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,859000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-971000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1828000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11979000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-7717000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4262000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4262000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4262000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35755000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35755000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2015.0,Q3,2014-12-01,2015-02-28,2016-04-11 16:26:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,83753000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,83753000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,40382000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,40382000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43371000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7914000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,21200000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6129000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4415000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1358000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2143000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43159000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,212000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,800000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-118000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-917000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-705000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,70000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-775000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-775000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-775000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35960000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35960000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38800000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q1,2015-06-01,2015-08-31,2016-10-05 13:31:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,89284000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,89284000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,43400000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,43400000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,45884000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8082000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,21378000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6179000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4483000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1284000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3913000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,45319000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,565000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,998000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-239000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1236000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-671000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-337000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-334000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-334000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-334000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36140000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36140000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33400000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q2,2015-09-01,2015-11-30,2017-01-06 15:06:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,87434000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,87434000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,43900000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,43900000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43534000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6901000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,20955000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5808000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4458000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,404000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3042000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41568000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1966000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,809000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-214000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1021000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,945000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,351000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,594000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,594000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,594000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36146000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36390000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29700000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q3,2015-12-01,2016-02-29,2017-04-03 10:55:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,93419000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,93419000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,51892000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,51892000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41527000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7686000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,20210000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6937000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4608000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,318000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3493000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43252000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1725000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,778000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-4000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-315000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1097000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2822000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,40253000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43075000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43075000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-43075000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36161383.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.2
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36161383.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.2
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36000000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2016.0,Q4,2016-03-01,2016-05-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.2
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,88098000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,88098000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,43066000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,43066000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,45032000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8201000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,19455000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6709000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4235000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,443000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2417000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41460000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3572000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,719000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,50000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-669000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2903000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1603000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1300000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1300000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1300000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36319000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36698000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32500000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q1,2016-06-01,2016-08-31,2017-09-29 15:18:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,89029000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,89029000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,44019000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,44019000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,45010000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7839000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,19469000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5913000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4291000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-15951000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,7861000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29422000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15588000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,810000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-363000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1173000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14415000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,681000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13734000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13734000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13734000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36807000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.37
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37146000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37100000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q2,2016-09-01,2016-11-30,2018-01-05 15:35:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.37
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,85602000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,85602000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,41810000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,41810000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43792000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7051000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,19418000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5951000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4360000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,122000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1750000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38652000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5140000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,627000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,44000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-583000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4557000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1670000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2887000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2887000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2887000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36625000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37126000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36100000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q3,2016-12-01,2017-02-28,2018-04-05 10:19:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7059000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7059000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-3057000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-3057000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10116000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8042000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,16523000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5575000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1714000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1712000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,15482000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,45624000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-35475000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,683000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-12000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-695000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-36170000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-11197000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24973000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,12060000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12913000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12913000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36616859.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36616859.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35800000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2017.0,Q4,2017-03-01,2017-05-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,85411000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,85411000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,44182000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,44182000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41229000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8056000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,19402000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6441000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4096000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,105000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2989000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41089000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,140000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,723000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,567000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-156000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-35000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36919000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36919000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q1,2017-06-01,2017-08-31,2018-10-01 16:54:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,83851000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,83851000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,38403000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,38403000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,45448000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7723000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,18009000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6457000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4191000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,31000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4177000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,40588000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4860000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,740000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-49000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-789000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4071000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-9948000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14019000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14019000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,14019000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37122000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37442000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36900000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2018.0,Q3,2017-12-01,2018-02-28,2019-04-02 15:20:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,63943000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,63943000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,27990000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,27990000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,35953000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8435000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,18405000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7374000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3434000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,12000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4422000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42082000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6129000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,917000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,114000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-803000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6932000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1228000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5704000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,5235000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-469000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-469000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37323000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37323000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46900000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q1,2018-06-01,2018-08-31,2019-10-04 15:37:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,69985000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,69985000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29433000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29433000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40552000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9262000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,19263000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7076000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4506000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,244000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2728000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43079000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2527000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1330000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,80000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1250000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3777000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-190000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3587000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,5727000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2140000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2140000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37500000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37500000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35700000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q2,2018-09-01,2018-11-30,2020-01-08 14:39:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.06
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,65524000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,65524000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,27361000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,27361000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38163000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8718000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,18385000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6915000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4660000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,609000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2550000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41837000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3674000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1442000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-266000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1708000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5382000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-773000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4609000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,5405000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,796000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,796000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37518000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37518000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39800000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q3,2018-12-01,2019-02-28,2020-04-08 15:56:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,71182000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,71182000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29850000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29850000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41332000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8487000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,20776000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6893000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4500000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-7685000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5427000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38442000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2934000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1410000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-135000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1545000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1389000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1365000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2754000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,56119000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,58873000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,58873000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37484573.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.57
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37485000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.57
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37400000.0
AngioDynamics Inc,ANGO,549300W3VKC5ZKMO8C28,0001275187,2019.0,Q4,2019-03-01,2019-05-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.57
